US OptionsDetailed Quotes
BZ240920C15000
- 0.39
- -0.06-13.33%
15min DelayTrading Aug 26 09:57 ET
0.40High0.39Low
0.40Open0.45Pre Close10 Volume536 Open Interest15.00Strike Price399.00Turnover48.86%IV9.73%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.39Extrinsic Value100Contract SizeAmericanOptions Type0.3365Delta0.2028Gamma33.00Leverage Ratio-0.0138Theta0.0030Rho11.11Eff Leverage0.0134Vega
Kanzhun Stock Discussion
Sign in to post a comment
$Kanzhun (BZ.US)$ BUY BUY BUY
1
Kanzhun's strong revenue growth, outperforming the industry, may justify its high P/S ratio for investors. If the company sustains this growth, the share price should remain supported.
4
Kanzhun's effective reinvestment activities steering it to profitability is commendable, suggesting a good investment opportunity despite the modest 4.8% return delivered to shareholders over the past year.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Clorox (CLX.US)$ - up 4.6%
2. $Cognizant (CTSH.US)$ - up 4.1%
3. $Informatica (INFA.US)$ - up 2.8%
4. $Kanzhun (BZ.US)$ - up 2.7%
5. $Sunrun (RUN.US)$ - up 2.6%
6. $Regeneron Pharmaceuticals (REGN.US)$ - up 1.9%
7. $McKesson (MCK.US)$ - up 1.9%
8. $Curtiss-Wright (CW.US)$ - up 1.7%
9. $MercadoLibre (MELI.US)$ - up 1.5...
Gap Ups
1. $Clorox (CLX.US)$ - up 4.6%
2. $Cognizant (CTSH.US)$ - up 4.1%
3. $Informatica (INFA.US)$ - up 2.8%
4. $Kanzhun (BZ.US)$ - up 2.7%
5. $Sunrun (RUN.US)$ - up 2.6%
6. $Regeneron Pharmaceuticals (REGN.US)$ - up 1.9%
7. $McKesson (MCK.US)$ - up 1.9%
8. $Curtiss-Wright (CW.US)$ - up 1.7%
9. $MercadoLibre (MELI.US)$ - up 1.5...
+16
21
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Domino's Pizza (DPZ.US)$ - up 8.7%
2. $POSCO (PKX.US)$ - up 5.2%
3. $Fresenius Medical Care (FMS.US)$ - up 4.6%
4. $Jefferies Financial (JEF.US)$ - up 3.8%
5. $STMicroelectronics (STM.US)$ - up 3.8%
6. $Kanzhun (BZ.US)$ - up 3.8%
7. $Bilibili (BILI.US)$ - up 3.7%
8. $Rio Tinto (RIO.US)$ - up 3....
Gap Ups
1. $Domino's Pizza (DPZ.US)$ - up 8.7%
2. $POSCO (PKX.US)$ - up 5.2%
3. $Fresenius Medical Care (FMS.US)$ - up 4.6%
4. $Jefferies Financial (JEF.US)$ - up 3.8%
5. $STMicroelectronics (STM.US)$ - up 3.8%
6. $Kanzhun (BZ.US)$ - up 3.8%
7. $Bilibili (BILI.US)$ - up 3.7%
8. $Rio Tinto (RIO.US)$ - up 3....
+11
15
1
$Kanzhun (BZ.US)$ so you’re looking good to Zacks model for him to place you in his top 5%(strong buy)of 4000 stocks aye? Not even just a Buy rating which is his next 15% of 4000 stocks! You definitely have to be something special to get a STRONG BUY RATING by Zack dudes model is a genius!Lets give her a go! Now im debating if i ahould have waited till after earnings report.🤔😅 Well if you cant take risks whats the point!!’ All in!!! ♥️🔥🦅♾
2
2
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $AngloGold Ashanti (AU.US)$ - up 2.2%
2. $AstraZeneca (AZN.US)$ - up 1.7%
3. $argenx SE (ARGX.US)$ - up 1.4%
4. $American Electric Power (AEP.US)$ - up 0.4%
5. $AmerisourceBergen (ABC.US)$ - up 0.3%
Gap Downs
1. $Albemarle (ALB.US)$ - down 2.9%
2. $ABB Ltd (ABB.US)$ - down 0.9%
3. $Kanzhun (BZ.US)$ - down 0....
Gap Ups
1. $AngloGold Ashanti (AU.US)$ - up 2.2%
2. $AstraZeneca (AZN.US)$ - up 1.7%
3. $argenx SE (ARGX.US)$ - up 1.4%
4. $American Electric Power (AEP.US)$ - up 0.4%
5. $AmerisourceBergen (ABC.US)$ - up 0.3%
Gap Downs
1. $Albemarle (ALB.US)$ - down 2.9%
2. $ABB Ltd (ABB.US)$ - down 0.9%
3. $Kanzhun (BZ.US)$ - down 0....
+10
9
1
BOSS Zhipin released its financial report for 2022. In 22Q4, it achieved revenue of 1.082 billion yuan (RMB, unless otherwise specified, the same below), which was flat year-on-year and fell by 8.2% month-on-month, mainly due to the impact of the epidemic. Among them, the online recruitment service business achieved revenue of 1.070 billion yuan, a year-on-year decr...
Core points:
1. In the fourth quarter, the company realized non-GAAP cash receipts (Non-GAAP) of RMB 1.1 billion, and GAAP income of RMB 1.08 billion, which was the same as the same period last year. For the full year of 2022, the company will achieve GAAP revenue of RMB 4.51 billion, and the calculated cash receipts (Non-GAAP) will be RMB 4.61 billion.
2. In the fourth quarter, the company did two major things. On Dece...
1. In the fourth quarter, the company realized non-GAAP cash receipts (Non-GAAP) of RMB 1.1 billion, and GAAP income of RMB 1.08 billion, which was the same as the same period last year. For the full year of 2022, the company will achieve GAAP revenue of RMB 4.51 billion, and the calculated cash receipts (Non-GAAP) will be RMB 4.61 billion.
2. In the fourth quarter, the company did two major things. On Dece...
Columns KANZHUN 22Q4 Earning Report: Performance Growth is Confirmed, But the Valuation Premium is too High
1. 22Q4 revenue is affected by macro headwinds, and the optimistic 23Q1 performance guidance is mainly driven by economic recovery
KANZHUN's 22Q4 revenue was 1.0823 billion yuan, a slight decline of less than 1% year-on-year. The revenue in 2022 will be 4.511 billion yuan, YoY+5.9%, slightly exceeding market expectations, reflecting that the company still maintains a certain degree of competitivene...
KANZHUN's 22Q4 revenue was 1.0823 billion yuan, a slight decline of less than 1% year-on-year. The revenue in 2022 will be 4.511 billion yuan, YoY+5.9%, slightly exceeding market expectations, reflecting that the company still maintains a certain degree of competitivene...
No comment yet
105516486 : Why nobody talking about this stock ? This the best stock fundamentals and technical analysis so far , any opinion ?